Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decrease in Brain Serotonin 2 Receptor Binding in Patients With Major Depression Following Desipramine Treatment
Lakshmi N. Yatham, Peter F. Liddle, Joelle Dennie, et al.
Archives of General Psychiatry (1999) Vol. 56, Iss. 8, pp. 705-705
Closed Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Neuroimaging studies of mood disorders
Wayne C. Drevets
Biological Psychiatry (2000) Vol. 48, Iss. 8, pp. 813-829
Closed Access | Times Cited: 1306
Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response
Helen S. Mayberg, Steven Brannan, Janet L. Tekell, et al.
Biological Psychiatry (2000) Vol. 48, Iss. 8, pp. 830-843
Closed Access | Times Cited: 1116
Serotonin and brain function: a tale of two receptors
RL Carhart-Harris, DJ Nutt
Journal of Psychopharmacology (2017) Vol. 31, Iss. 9, pp. 1091-1120
Open Access | Times Cited: 593
Can stress cause depression?
H. M. van Praag
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2004) Vol. 28, Iss. 5, pp. 891-907
Closed Access | Times Cited: 357
Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
Michael Kometer, André Schmidt, Rosilla Bachmann, et al.
Biological Psychiatry (2012) Vol. 72, Iss. 11, pp. 898-906
Closed Access | Times Cited: 264
Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter
Craig A. Stockmeier
Journal of Psychiatric Research (2003) Vol. 37, Iss. 5, pp. 357-373
Closed Access | Times Cited: 343
Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain
Michael Bauer, Andreas Heinz, Peter C. Whybrow
Molecular Psychiatry (2002) Vol. 7, Iss. 2, pp. 140-156
Closed Access | Times Cited: 328
An analysis of functional neuroimaging studies of dorsolateral prefrontal cortical activity in depression
Paul B. Fitzgerald, Thomas J. Oxley, Angela R. Laird, et al.
Psychiatry Research Neuroimaging (2006) Vol. 148, Iss. 1, pp. 33-45
Closed Access | Times Cited: 247
The Effect of Paroxetine on 5-HT2A Receptors in Depression: An [18F]Setoperone PET Imaging Study
Jeffrey H. Meyer, Shitij Kapur, Beata S. Eisfeld, et al.
American Journal of Psychiatry (2001) Vol. 158, Iss. 1, pp. 78-85
Closed Access | Times Cited: 224
Pharmacology of antidepressants
Elliott Richelson
Mayo Clinic Proceedings (2001) Vol. 76, Iss. 5, pp. 511-527
Open Access | Times Cited: 192
Early Changes in Prefrontal Activity Characterize Clinical Responders to Antidepressants
Ian A. Cook
Neuropsychopharmacology (2002) Vol. 27, Iss. 1, pp. 120-131
Open Access | Times Cited: 191
Can stress cause depression?
H. M. van Praag
The World Journal of Biological Psychiatry (2005) Vol. 6, Iss. sup2, pp. 5-22
Closed Access | Times Cited: 180
HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions
Masako Aihara, Itsuro Ida, Naoya Yuuki, et al.
Psychiatry Research Neuroimaging (2007) Vol. 155, Iss. 3, pp. 245-256
Closed Access | Times Cited: 165
Pharmacogenetics of antidepressant response
Stefano Porcelli, Antonio Drago, Chiara Fabbri, et al.
Journal of Psychiatry and Neuroscience (2011) Vol. 36, Iss. 2, pp. 87-113
Open Access | Times Cited: 161
Overlapping neurobiology of learned helplessness and conditioned defeat: Implications for PTSD and mood disorders
Sayamwong E. Hammack, Matthew A. Cooper, Kimberly R. Lezak
Neuropharmacology (2011) Vol. 62, Iss. 2, pp. 565-575
Open Access | Times Cited: 131
Pesticides, cognitive functions and dementia: A review
Athina‐Maria Aloizou, Vasileios Siokas, Christina Vogiatzi, et al.
Toxicology Letters (2020) Vol. 326, pp. 31-51
Closed Access | Times Cited: 118
Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies
Margaret T. Davis, Sophie Holmes, Robert H. Pietrzak, et al.
Chronic Stress (2017) Vol. 1
Open Access | Times Cited: 116
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder
Joshua D. Rosenblat, M. Ishrat Husain, Yena Lee, et al.
The Canadian Journal of Psychiatry (2022) Vol. 68, Iss. 1, pp. 5-21
Open Access | Times Cited: 38
Brain Serotonin2 Receptors in Major Depression
Lakshmi N. Yatham, Peter F. Liddle, I‐Shin Shiah, et al.
Archives of General Psychiatry (2000) Vol. 57, Iss. 9, pp. 850-850
Closed Access | Times Cited: 171
Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography
Mark A. Mintun, Yvette I. Sheline, Stephen M. Moerlein, et al.
Biological Psychiatry (2003) Vol. 55, Iss. 3, pp. 217-224
Closed Access | Times Cited: 160
Permanent, Sex-Selective Effects of Prenatal or Adolescent Nicotine Exposure, Separately or Sequentially, in Rat Brain Regions: Indices of Cholinergic and Serotonergic Synaptic Function, Cell Signaling, and Neural Cell Number and Size at 6 Months of Age
Theodore A. Slotkin, Emiko A. MacKillop, Charles L Rudder, et al.
Neuropsychopharmacology (2006) Vol. 32, Iss. 5, pp. 1082-1097
Open Access | Times Cited: 151
S33005, a Novel Ligand at Both Serotonin and Norepinephrine Transporters: I. Receptor Binding, Electrophysiological, and Neurochemical Profile in Comparison with Venlafaxine, Reboxetine, Citalopram, and Clomipramine
M J Millan, Alain P. Gobert, F. Lejeune, et al.
Journal of Pharmacology and Experimental Therapeutics (2001) Vol. 298, Iss. 2, pp. 565-580
Closed Access | Times Cited: 137
G protein-coupled receptors in major psychiatric disorders
Lisa A. Catapano, Husseini K. Manji
Biochimica et Biophysica Acta (BBA) - Biomembranes (2006) Vol. 1768, Iss. 4, pp. 976-993
Open Access | Times Cited: 130
Organophosphate Insecticides Target the Serotonergic System in Developing Rat Brain Regions: Disparate Effects of Diazinon and Parathion at Doses Spanning the Threshold for Cholinesterase Inhibition
Theodore A. Slotkin, Charlotte A. Tate, Ian T. Ryde, et al.
Environmental Health Perspectives (2006) Vol. 114, Iss. 10, pp. 1542-1546
Open Access | Times Cited: 116
Pharmacogenetics of Antidepressants
Concetta Crisafulli, Chiara Fabbri, Stefano Porcelli, et al.
Frontiers in Pharmacology (2011) Vol. 2
Open Access | Times Cited: 103
Page 1 - Next Page

Scroll to top